Literature DB >> 20362547

Enhancement of TREK1 channel surface expression by protein-protein interaction with beta-COP.

Eunju Kim1, Eun Mi Hwang, Oleg Yarishkin, Jae Cheal Yoo, Donggyu Kim, Nammi Park, Minhee Cho, Young Sun Lee, Choong-Hyun Sun, Gwan-Su Yi, Jiyun Yoo, Dawon Kang, Jaehee Han, Seong-Geun Hong, Jae-Yong Park.   

Abstract

TREK1 belongs to a family of two-pore-domain K(+) (K(2P)) channels and produce background currents that regulate cell excitability. In the present study, we identified a vesicle transport protein, beta-COP, as an interacting partner by yeast two-hybrid screening of a human brain cDNA library with N-terminal region of TREK1 (TREK1-N) as bait. Several in vitro and in vivo binding assays confirmed the protein-protein interaction between TREK1 and beta-COP. We also found that beta-COP was associated with TREK1 in native condition at the PC3 cells. When RFP-beta-COP was co-transfected with GFP-TREK1 into COS-7 cells, both proteins were found localized to the plasma membrane. In addition, the channel activity and surface expression of GFP-TREK1 increased dramatically by co-transfection with RFP-beta-COP. Surface expression of the TREK1 channel was also clearly reduced with the addition of beta-COP-specific shRNA. Collectively, these data suggest that beta-COP plays a critical role in the forward transport of TREK1 channel to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362547     DOI: 10.1016/j.bbrc.2010.03.171

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.

Authors:  M Borsotto; J Veyssiere; H Moha Ou Maati; C Devader; J Mazella; C Heurteaux
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 2.  The family of K2P channels: salient structural and functional properties.

Authors:  Sylvain Feliciangeli; Frank C Chatelain; Delphine Bichet; Florian Lesage
Journal:  J Physiol       Date:  2015-01-22       Impact factor: 5.182

3.  Variants of stretch-activated two-pore potassium channel TREK-1 associated with preterm labor in humans.

Authors:  Yi-Ying Wu; Cherie A Singer; Iain L O Buxton
Journal:  Biol Reprod       Date:  2012-10-25       Impact factor: 4.285

Review 4.  Molecular regulations governing TREK and TRAAK channel functions.

Authors:  Jacques Noël; Guillaume Sandoz; Florian Lesage
Journal:  Channels (Austin)       Date:  2011-09-01       Impact factor: 2.581

5.  Identification and characterization of alternative splice variants of the mouse Trek2/Kcnk10 gene.

Authors:  K Mirkovic; K Wickman
Journal:  Neuroscience       Date:  2011-07-31       Impact factor: 3.590

6.  The inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on K2P (two-pore domain potassium) channel TREK-1.

Authors:  Hye Won Shin; Jeong Seop Soh; Hee Zoo Kim; Jinpyo Hong; Dong Ho Woo; Jun Young Heo; Eun Mi Hwang; Jae-Yong Park; C Justin Lee
Journal:  J Anesth       Date:  2014-02       Impact factor: 2.078

Review 7.  TREK-king the blood-brain-barrier.

Authors:  Stefan Bittner; Tobias Ruck; Juncal Fernández-Orth; Sven G Meuth
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-21       Impact factor: 4.147

8.  Alternatively Spliced Human TREK-1 Variants Alter TREK-1 Channel Function and Localization.

Authors:  Chad L Cowles; Yi-Ying Wu; Scott D Barnett; Michael T Lee; Heather R Burkin; Iain L O Buxton
Journal:  Biol Reprod       Date:  2015-09-23       Impact factor: 4.285

Review 9.  Two-pore Domain Potassium Channels in Astrocytes.

Authors:  Kanghyun Ryoo; Jae-Yong Park
Journal:  Exp Neurobiol       Date:  2016-10-26       Impact factor: 3.261

Review 10.  The Popeye domain containing protein family--A novel class of cAMP effectors with important functions in multiple tissues.

Authors:  Roland F R Schindler; Thomas Brand
Journal:  Prog Biophys Mol Biol       Date:  2016-01-07       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.